{"id":"ttva","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_fixedAt":"2026-03-30T11:48:35.455049","_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"TTVA works by stimulating the body's immune system to produce antibodies and immune cells that can recognize and fight the SARS-CoV-2 virus. This is achieved through the use of a viral vector that carries a gene from the SARS-CoV-2 virus, which is then expressed by cells in the body and triggers an immune response.","oneSentence":"TTVA is a vaccine that induces an immune response against the SARS-CoV-2 virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:06.020Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of COVID-19 disease caused by SARS-CoV-2 virus"}]},"_fixedFields":["pubmed(11)"],"trialDetails":[{"nctId":"NCT06120751","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over","status":"COMPLETED","sponsor":"CanSino Biologics Inc.","startDate":"2024-03-20","conditions":"Tetanus","enrollment":1000},{"nctId":"NCT06123663","phase":"PHASE1","title":"A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over","status":"COMPLETED","sponsor":"CanSino Biologics Inc.","startDate":"2023-12-20","conditions":"Tetanus","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"recentPublications":[{"date":"2026 Feb 9","pmid":"41396091","title":"GLIDE Score is associated with procedural success in patients undergoing direct transcatheter tricuspid valve annuloplasty.","journal":"European heart journal. Cardiovascular Imaging"},{"date":"2025 Dec 8","pmid":"41371787","title":"Transcatheter Tricuspid Valve Annuloplasty: A Note of Caution.","journal":"JACC. Cardiovascular interventions"},{"date":"2025 Dec 8","pmid":"41371786","title":"Cardiac Remodeling Following Transcatheter Tricuspid Valve Annuloplasty for Tricuspid Regurgitation: A Real-World, Multicenter Analysis.","journal":"JACC. Cardiovascular interventions"},{"date":"2025 Sep","pmid":"40888413","title":"Hemodynamic Effects of Transcatheter Tricuspid Valve Annuloplasty With Cardioband and Their Associations With Clinical Outcomes.","journal":"Circulation. Cardiovascular interventions"},{"date":"2025 Jul","pmid":"40063122","title":"Cardiac implantable electronic device carriers undergoing transcatheter tricuspid valve annuloplasty: real-world insights.","journal":"Clinical research in cardiology : official journal of the German Cardiac Society"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"TTVA","genericName":"TTVA","companyName":"CanSino Biologics Inc.","companyId":"cansino-biologics-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"TTVA is a vaccine that induces an immune response against the SARS-CoV-2 virus. Used for Prevention of COVID-19 disease caused by SARS-CoV-2 virus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}